✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CancerPrecision MedicineDrug DeliveryResearchTherapeutics Why This MattersPrecision-targeted DNA therapeutics represent a potential paradigm shift in...
Cannabinoid Chewing Gum: Promising Concept, Thin Evidence
Despite a long-standing widespread history of chewing gum use in general, there is sparse experience and even less clinical research on the effects and possible clinical value of incorporating cannabidiol or any other cannabinoid in a chewing gum product.
CBD Chewing Gum: Promising Concept, Thin Evidence
Despite promising reports, research gaps remain, particularly in understanding the absorption mechanisms, dosing precision, and long-term safety of cannabinoid-based chewing gum.
Rapid Dose Therapeutics Reinforces Strategic Strength and Global Growth Trajectory
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PharmaceuticalsDrug DeliveryIndustryProduct Access Why This MattersCorporate expansion announcements from cannabis pharmaceutical companies signal potential...
Cannabidiol-Loaded Mucoadhesive PLGA Nanosphere-Chitosan Hydrogel Patch for Oral Therapeutic Applications.
Cannabidiol (CBD), the primary bioactive element of cannabis, has shown promise in alleviating pain and inflammation, although mechanisms in periodontal infl…
Inside the FIRST Controlled Cannabis Airflow Trial with Dr. Allison Justice – YouTube
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic InhalationDosingPharmacokineticsClinical ResearchDrug Delivery Why This MattersControlled airflow studies represent a critical step toward...
Nexalis (formerly InhaleRx) initiates Phase 1 trial of IRX-616a CBD MDI – OINDP News
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic CbdDrug DeliveryPharmacokineticsClinical TrialsRespiratory Why This MattersThe development of a metered-dose inhaler (MDI) for...
Hemp-Derived Extracellular Vesicles: A Novel Frontier in Nanomedicine and Therapeutics.
While mammalian-derived extracellular vesicles (EVs) face significant challenges in clinical translation due to scalability, cost, and safety, plant-derived …
Leading Cannabis Brand Select Unveils Briq 2, the New Gold Standard for Smooth, Flavorful Vaping
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic VaporizationMedical DevicesDrug DeliveryPatient Safety Why This MattersVaping device technology directly impacts bioavailability, dosing precision,...
Inhaled CBD Reduces Key Neuroinflammatory Markers in Alzheimer’s Mouse Model
CBD treatment significantly reduced IDO and cGAS expression, correlating with decreased proinflammatory cytokines, including TNF-ฮฑ, IL-1ฮฒ, and IFN-ฮณ. These findings support CBD as a potential monotherapy or adjunctive treatment for AD by targeting distinct neuroinflammatory pathways.